Sestamibi and Other Technetium-99m Perfusion Agents

[1]  J P Ornato,et al.  Comprehensive strategy for the evaluation and triage of the chest pain patient. , 1997, Annals of emergency medicine.

[2]  D. Berman,et al.  Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  R. Gibbons,et al.  Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Soc , 1995, Circulation.

[4]  T. Hilton,et al.  748-1 Ninety Day Follow-up of Emergency Department Patients with Chest Pain and Normal or Non-diagnostic ECG Who Undergo Acute Cardiac Imaging with Tc-99m Sestamibi , 1995 .

[5]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.

[6]  G Germano,et al.  Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. , 1994, Journal of the American College of Cardiology.

[7]  Randall C. Thompson,et al.  Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. , 1994, Journal of the American College of Cardiology.

[8]  D. Berman,et al.  Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  D. Berman,et al.  Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  C. Orlandi,et al.  Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. , 1993, Journal of the American College of Cardiology.

[11]  R. Gibbons,et al.  Determinants of Infarct Size in Reperfusion Therapy for Acute Myocardial Infarction , 1992, Circulation.

[12]  V. Dilsizian,et al.  Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  D. Gagnon,et al.  Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. , 1991, Journal of the American College of Cardiology.

[14]  P. McLaughlin,et al.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? , 1990, Circulation.

[15]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[16]  P. Théroux,et al.  Detection and assessment of unstable angina using myocardial perfusion imaging: comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram. , 1990, The American journal of cardiology.

[17]  W. Shell,et al.  Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris. , 1990, The American journal of cardiology.

[18]  R. Okada,et al.  Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. , 1990, Circulation.

[19]  R. Gibbons,et al.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. , 1989, Circulation.

[20]  R. Okada,et al.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. , 1988, Circulation.

[21]  D. Durrer,et al.  Potential value of thallium-201 scintigraphy as a means of selecting patients for the coronary care unit. , 1979, British heart journal.